SI-BONE Inc.

AI Score

XX

Unlock

13.88
0.55 (4.13%)
At close: Apr 17, 2025, 3:59 PM
13.86
-0.18%
After-hours: Apr 17, 2025, 04:09 PM EDT
4.13%
Bid 11.88
Market Cap 589.46M
Revenue (ttm) 167.18M
Net Income (ttm) -30.91M
EPS (ttm) -0.75
PE Ratio (ttm) -18.51
Forward PE -27.69
Analyst Buy
Ask 14.81
Volume 326,731
Avg. Volume (20D) 388,732
Open 13.75
Previous Close 13.33
Day's Range 13.01 - 13.94
52-Week Range 11.70 - 19.16
Beta 1.02

About SIBN

SI-BONE, Inc., a medical device company, develops implantable devices used to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers iFuse, a minimally invasive surgical implant system to address sacroiliac joint dysfunction and degeneration, adult deformity, and pelvic ring traumatic fractures. The company also provides iFuse-3D, a titanium implant that combines the triangular cross-section...

Sector Healthcare
IPO Date Oct 17, 2018
Employees 349
Stock Exchange NASDAQ
Ticker Symbol SIBN
Full Company Profile

Analyst Forecast

According to 6 analyst ratings, the average rating for SIBN stock is "Buy." The 12-month stock price forecast is $24.5, which is an increase of 76.45% from the latest price.

Stock Forecasts

Next Earnings Release

SI-BONE Inc. is scheduled to release its earnings on May 5, 2025, after market closes.
Analysts project revenue of ... Unlock content with Pro Subscription
1 month ago
+5.55%
SI-BONE shares are trading higher after the compan... Unlock content with Pro Subscription
3 months ago
+18.29%
SI-BONE shares are trading higher after the company reported preliminary Q4 revenue results.